Events and Webcasts
Upcoming Events
There are currently no events to display.
Past Events
-
aTyr Pharma at the Baird 2018 Global Healthcare Conference
Sep 6, 2018 12:15 PM EDTSupporting Materials
-
aTyr Pharma Second Quarter 2018 Operating Results Conference Call
Aug 14, 2018 2:00 PM PDT -
Poster Presentation: ATYR1923 Ameliorates Dermal and Pulmonary Fibrosis in a Murine Model of Sclerodermatous Chronic Graft vs. Host Disease
Jul 27, 2018 5:00 PM EDTSupporting Materials
Poster Presentation 602 KB -
aTyr Pharma at the Jefferies 2018 Global Healthcare Conference
Jun 7, 2018 9:30 AM EDTSupporting Materials
Location:New York, NY -
Poster Presentation: Preclinical Characterization of Atyr1923 (Imod.Fc), An Immune-Modulatory Therapeutic With Potentially Broad Application In Interstitial Lung Diseases
May 20, 2018 9:15 AM PDTSupporting Materials
Poster Presentation 913 KBPoster Session: Sunday May 20, 2018 from 9:15 am – 11:15 am (PT) -
aTyr Pharma 2018 Annual Meeting of Stockholders
May 15, 2018 8:30 AM EDT -
aTyr Pharma First Quarter 2018 Operating Results Conference Call
May 14, 2018 8:00 AM EDT -
Poster Presentation: Identification of a T Cell Immunomodulatory Domain In Histidyl-Trna Synthetase
May 6, 2018Supporting Materials
Poster Presentation 1.2 MBPoster Session: Sunday, May 6, 2018 from 2:30 pm – 3:45 pm (CT) -
Poster Presentation: Antibodies Targeting Resokine, a Soluble Immune Modulator, Inhibit Tumor Growth In Syngeneic Mouse Models
Apr 17, 2018Supporting Materials
Poster Presentation 1.4 MBPoster Session: Tuesday, April 17, 2018 from 8:00 am – 12:00 pm (CT) -
Poster Presentation: Circulating Levels of Resokine, a Soluble Modulator of the Immune System, are Upregulated in both Experimental Cancer Models and in Patients Across Multiple Tumor Types
Apr 16, 2018Supporting Materials
Poster Presentation 895 KBPoster Session: Monday, April 16, 2018 from 1:00 pm – 5:00 pm (CT) -
aTyr Pharma Fourth Quarter and Full Year 2017 Operating Results Conference Call
Mar 19, 2018 2:00 PM PDT -
aTyr Pharma at the Barclays Global Healthcare Conference
Mar 15, 2018 2:05 PM EDTLocation:Miami, FLThere will be no webcast presentation for this event. -
aTyr Pharma at the Cowen and Company 38th Annual Health Care Conference
Mar 12, 2018 11:20 AM EDT -
Poster Presentation: Identification of Novel Liquid Biopsy Biomarker for Monitoring the Immune Set Point in Both Solid Tumor and Hematological Malignancy Patients
Jan 25, 2018Supporting Materials
Poster Presentation 617.4 KBPoster Session: Thursday, January 25, 2018 from 11:30 am – 1:00 pm (PT) and 5:30 pm – 6:30 pm (PT)
-
aTyr Pharma at the 36th Annual J.P. Morgan Healthcare Conference
Jan 11, 2018 8:00 AM PSTLocation:San Francisco, CA -
aTyr Pharma at the BMO Prescriptions for Success Healthcare Conference
Dec 14, 2017 8:30 AM EST -
aTyr Pharma at the 29th Annual Piper Jaffray Healthcare Conference
Nov 29, 2017 8:00 AM ESTLocation:Lotte New York Palace Hotel, New York, NY -
Poster Presentation: Results of a Phase 1b/2 Study of ATYR1940 in Adolescents and Young Adults With Early-onset Facioscapulohumeral Muscular Dystrophy (FSHD) (ATYR1940-C-003)
Oct 5, 2017 3:30 PM CESTSupporting Materials
Poster Presentation 387.3 KB -
aTyr Pharma at the Ladenburg Thalmann 2017 Healthcare Conference
Sep 26, 2017 11:30 AM EDTLocation:New York, NY -
aTyr Pharma at the Jefferies 2017 Global Healthcare Conference
Jun 9, 2017 2:00 PM EDTLocation:New York, NY -
Educational Webinar on Interstitial Lung Disease and aTyr’s iMod.Fc Program at the American Thoracic Society International Congress
May 23, 2017 8:30 AM EDTOn Tuesday, May 23, 2017 at 8:30 a.m. ET, aTyr Pharma will host a conference call and webcast with an accompanying slide presentation to discuss interstitial lung disease and the iMod.Fc program. Joining the aTyr Pharma management will be Steven D. Nathan, M.D., FCCP, Director of the Advanced Lung Disease Program and Medical Director of the Lung Transplant Program at Inova Fairfax Hospital. To access the call, please dial 844-358-9116 (domestic) or 209-905-5951 (international) and ask to join the aTyr Pharma call. -
Poster Presentation: Results of a Phase 1b/2 Study of ATYR1940 in Adult Patients with Limb Girdle Muscular Dystrophy Type 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD) (ATYR1940-C-004)
Apr 25, 2017 5:45 PM EDTSupporting Materials
Poster Presentation 161.1 KB -
Needham and Company 16th Annual Healthcare Conference
Apr 4, 2017 8:40 AM EDT -
Cowen and Company 37th Annual Health Care Conference
Mar 7, 2017 8:00 AM EST -
35th Annual J.P. Morgan Healthcare Conference
Jan 12, 2017 9:00 AM PST -
aTyr Pharma Clinical Development Update for Resolaris
Dec 13, 2016 8:30 AM EST -
Credit Suisse's 25th Annual Healthcare Conference
Nov 7, 2016 2:00 PM MST -
Poster Presentation: Resolaris™ Phase 1b/2 (002) Trial in Adult FSHD Patients at Annual Congress of World Muscle Society
Oct 6, 2016 3:00 PM CDTSupporting Materials
Poster Presentation 637.4 KB